CGAS and neoplasm: This indicated that the peptide loaded on the wild‐type, but not the cGAS silencing, tumor cell surface enhanced the activity of effector/memory CD8+ T cells in vitro, suggesting that cGAS silencing in the target tumor cells might hinder the further activation of CD8+ T cells.